SciVision Biotech Inc
TWSE:1786
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SciVision Biotech Inc
TWSE:1786
|
TW |
|
Chateau International Development Co Ltd
TWSE:2722
|
TW |
|
Logic Instrument SA
PAR:ALLOG
|
FR |
Intrinsic Value
The intrinsic value of SciVision Biotech Inc (1786) under the Base Case is 79.93 TWD per share.
Compared with the current market price of 39.7 TWD, the stock appears
Undervalued by 50% .
The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 9% a year over the next five years, below its five-year pace of 14%. If revenue grew at its five-year pace of 14%, the estimate would be about NT$116.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What SciVision Biotech Does
SciVision Biotech is a Taiwan-based eye-care company that makes and sells products used to treat and manage vision-related conditions. Its business centers on ophthalmic medicines and related eye-care products, such as treatments used in clinics, hospitals, and pharmacies for common problems like dry eye and other eye disorders.
- Headquarters
- Taiwan TW
- IPO date
- Dec 29, 2010
Revenue & Expenses Breakdown
SciVision Biotech Inc
Earnings Waterfall
SciVision Biotech Inc
The intrinsic value for SciVision Biotech Inc (1786) under the Base Case is 79.93 TWD.
Compared with the current market price of 39.7 TWD, the stock appears Undervalued by 50% .